Ionolyte (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Sodium Acetate Trihydrate)

Magnesium chloride hexahydrate dissociates after infusion, releasing magnesium ions that act as cofactors for many enzymatic reactions, help stabilise cell membranes, and support neuromuscular function. Together with potassium, sodium and acetate, it restores the normal ionic composition of extracellular fluid.

The prescribed dose of Ionolyte is determined by the treating clinician based on the patient’s electrolyte levels, fluid status, renal function and clinical condition. The healthcare professional sets the infusion rate and total volume required for each individual case.

The safety of Ionolyte in pregnancy and lactation has not been established. Clinicians should consider the potential benefits against possible risks and use the product only if clearly needed, following local regulatory guidance.

To order Ionolyte, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Ionolyte provides a balanced combination of magnesium, potassium, sodium and acetate, whereas many standard electrolyte solutions contain only sodium and chloride. The added magnesium and acetate can be advantageous in patients with specific deficiencies or metabolic needs, but selection should be based on individual electrolyte profiles and clinical judgment.

Ionolyte should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the solution from direct sunlight, moisture and extreme temperature fluctuations. Do not freeze the product, and inspect the container for any damage before use.

Ionolyte is administered intravenously. The solution is typically infused through a peripheral or central venous line using an infusion pump or gravity drip, with the rate adjusted according to the patient’s electrolyte targets and fluid requirements as ordered by the prescriber.

Serious risks include severe hypermagnesemia or hyperkalemia, which can cause cardiac arrhythmias or arrest, anaphylactic reactions, marked hypernatremia leading to neurological complications, and acute renal failure in susceptible individuals. Continuous monitoring of electrolyte levels and cardiac status is essential.

Ionolyte is contraindicated in patients with known hypersensitivity to any of its components, as well as those with existing hypermagnesemia, hyperkalemia, or hypernatremia. Caution is also advised for individuals with severe renal impairment, uncontrolled heart block, or those receiving interacting medications without appropriate monitoring.